Menin-MLL protein-protein interaction inhibitors: a patent review (2014–2021)
Author:
Affiliation:
1. Department of Medicinal Chemistry School of Pharmacy, Xi’an Jiaotong University, Xi’an, Shaanxi, 710061, PR China
2. Hebei Chemical & Pharmaceutical College, Shijiazhuang 050000, P.R. China
Publisher
Informa UK Limited
Subject
Drug Discovery,Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/13543776.2022.2045947
Reference92 articles.
1. MLL translocations, histone modifications and leukaemia stem-cell development
2. Pbx3 and Meis1 cooperate through multiple mechanisms to support Hox-induced murine leukemia
3. Direct and Indirect Targeting of HOXA9 Transcription Factor in Acute Myeloid Leukemia.
4. Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization
5. The same site on the integrase-binding domain of lens epithelium–derived growth factor is a therapeutic target for MLL leukemia and HIV
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic Targeting of the Menin–KMT2A Interaction;Annual Review of Cancer Biology;2024-06-12
2. Discovery of novel pyrrolo[2,3-d]pyrimidines as potent menin-mixed lineage leukemia interaction inhibitors;European Journal of Medicinal Chemistry;2024-03
3. Epigenetic drug screening for trophoblast syncytialization reveals a novel role for MLL1 in regulating fetoplacental growth;BMC Medicine;2024-02-05
4. The future of HOXA-expressing leukemias: Menin inhibitor response and resistance;Current Opinion in Hematology;2023-11-23
5. Dependency of B-Cell Acute Lymphoblastic Leukemia and Multiple Myeloma Cell Lines on MEN1 Extends beyond MEN1–KMT2A Interaction;International Journal of Molecular Sciences;2023-11-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3